Holly W. Smith

1.8k total citations
22 papers, 1.3k citations indexed

About

Holly W. Smith is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Holly W. Smith has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Immunology. Recurrent topics in Holly W. Smith's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Biosimilars and Bioanalytical Methods (7 papers) and Protein purification and stability (5 papers). Holly W. Smith is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Biosimilars and Bioanalytical Methods (7 papers) and Protein purification and stability (5 papers). Holly W. Smith collaborates with scholars based in United States and United Kingdom. Holly W. Smith's co-authors include Gopi Shankar, Michael Moxness, Linda A. Zuckerman, Boris Gorovits, Viswanath Devanarayan, Deborah Finco‐Kent, Valerie Quarmby, Eugen Koren, Lakshmi Amaravadi and Anthony Butterfield and has published in prestigious journals such as Environmental Science & Technology, PLoS ONE and Journal of Agricultural and Food Chemistry.

In The Last Decade

Holly W. Smith

21 papers receiving 1.2k citations

Peers

Holly W. Smith

IMMUN

RNMI

ONCOL

GENET

Deborah Finco‐Kent United States

Ming Gui China

M L Blue United States

Hitoo Iwase Japan

Karin Sege Sweden

Dharmesh D. Desai United States

Bruce Rankin United States

Yoichi Tatsumi Japan

John O. Phillips United States

Pernilla Jirholt Sweden

Deborah Finco‐Kent United States

Holly W. Smith

681 ×0.9

IMMUN

514 ×0.7

RNMI

386 ×0.6

165 ×0.8

ONCOL

197 ×2.4

GENET

Citations per year, relative to Holly W. Smith Holly W. Smith (= 1×) peers Deborah Finco‐Kent

Countries citing papers authored by Holly W. Smith

Since Specialization

Citations

This map shows the geographic impact of Holly W. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly W. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly W. Smith more than expected).

Fields of papers citing papers by Holly W. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly W. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly W. Smith. The network helps show where Holly W. Smith may publish in the future.

Co-authorship network of co-authors of Holly W. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Holly W. Smith. A scholar is included among the top collaborators of Holly W. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly W. Smith. Holly W. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, Holly W., et al.. (2018). The Effects of Whole Blood Centrifugation on Hemoglobin A1c Measurement. 3(1).

Byrd, Richard A., Steven D. Sorden, Thomas E. Ryan, et al.. (2015). Chronic Toxicity and Carcinogenicity Studies of the Long-Acting GLP-1 Receptor Agonist Dulaglutide in Rodents. Endocrinology. 156(7). 2417–2428. 21 indexed citations

Mikaelian, Igor, Mark J. Cameron, Deidre A. Dalmas, et al.. (2014). Nonclinical Safety Biomarkers of Drug-induced Vascular Injury. Toxicologic Pathology. 42(4). 635–657. 25 indexed citations

Adams, Andrew C., Barbara C. Hansen, Armando R. Irizarry, et al.. (2013). LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys. PLoS ONE. 8(6). e65763–e65763. 142 indexed citations

Smith, Holly W., Michael Moxness, & Robin Marsden. (2011). Summary of Confirmation Cut Point Discussions. The AAPS Journal. 13(2). 227–229. 14 indexed citations

Schultze, A. Eric, et al.. (2011). A Comparison of Mortality and Cardiac Biomarker Response between Three Outbred Stocks of Sprague Dawley Rats Treated with Isoproterenol. Toxicologic Pathology. 39(4). 576–588. 14 indexed citations

Ponce, Rafael, Leslie W. Abad, Lakshmi Amaravadi, et al.. (2009). Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies. Regulatory Toxicology and Pharmacology. 54(2). 164–182. 179 indexed citations

Butterfield, Anthony, et al.. (2009). Electrochemiluminescent immunoassay for rat skeletal troponin I (Tnni2) in serum. Journal of Pharmacological and Toxicological Methods. 61(1). 52–58. 8 indexed citations

Koren, Eugen, Holly W. Smith, Elizabeth W. Shores, et al.. (2008). Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products. Journal of Immunological Methods. 333(1-2). 1–9. 231 indexed citations

10.

Shankar, Gopi, Viswanath Devanarayan, Lakshmi Amaravadi, et al.. (2008). Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products. Journal of Pharmaceutical and Biomedical Analysis. 48(5). 1267–1281. 444 indexed citations

11.

Smith, Holly W., et al.. (2007). Detection of antibodies against therapeutic proteins in the presence of residual therapeutic protein using a solid-phase extraction with acid dissociation (SPEAD) sample treatment prior to ELISA. Regulatory Toxicology and Pharmacology. 49(3). 230–237. 83 indexed citations

12.

Spokas, Eric G., Bernd W. Spur, Holly W. Smith, Francis W. Kemp, & John D. Bogden. (2006). Tissue Lead Concentration during Chronic Exposure of Pimephales promelas (Fathead Minnow) to Lead Nitrate in Aquarium Water. Environmental Science & Technology. 40(21). 6852–6858. 16 indexed citations

13.

Smith, Holly W. & Daniel Wierda. (2005). Preclinical Immunogenicity Testing for Recombinant Therapeutic Proteins. Journal of Immunotoxicology. 2(4). 203–210. 3 indexed citations

14.

Smith, Holly W., et al.. (2003). A predictive F344 rat immunotoxicology model: cellular parameters combined with humoral response to NP-CγG and KLH. Toxicology. 194(1-2). 129–145. 20 indexed citations

15.

Wierda, Daniel, Holly W. Smith, & Craig Zwickl. (2001). Immunogenicity of biopharmaceuticals in laboratory animals. Toxicology. 158(1-2). 71–74. 35 indexed citations

16.

Zwickl, Craig, et al.. (1996). Immunogenicity of Tissue Plasminogen Activators in Rhesus Monkeys: Antibody Formation and Effects on Blood Level and Enzymatic Activity. Toxicological Sciences. 30(2). 243–254. 2 indexed citations

17.

Zwickl, Craig, et al.. (1995). Immunogenicity of biosynthetic human LysPro insulin compared to native-sequence human and purified porcine insulins in rhesus monkeys immunized over a 6-week period.. PubMed. 45(4). 524–8. 14 indexed citations

18.

Bick, Peter H., et al.. (1990). Antibody responses to recombinant bovine somatotropin in dairy cattle. Animal Biotechnology. 1(1). 61–71. 5 indexed citations

19.

Zwickl, Craig, Holly W. Smith, R. Tamura, & Peter H. Bick. (1990). Somatotropin Antibody Formation in Cows Treated with a Recombinant Bovine Somatotropin Over Two Lactations. Journal of Dairy Science. 73(10). 2888–2895. 16 indexed citations

20.

Smith, Holly W., et al.. (1985). A Universal HPLC Determination of Insulin Potency. Journal of Liquid Chromatography. 8(3). 419–439. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact